SG10201710439UA - Methods of purifying polypeptides - Google Patents
Methods of purifying polypeptidesInfo
- Publication number
- SG10201710439UA SG10201710439UA SG10201710439UA SG10201710439UA SG10201710439UA SG 10201710439U A SG10201710439U A SG 10201710439UA SG 10201710439U A SG10201710439U A SG 10201710439UA SG 10201710439U A SG10201710439U A SG 10201710439UA SG 10201710439U A SG10201710439U A SG 10201710439UA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- purifying polypeptides
- polypeptides
- purifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3847—Multimodal interactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34814310P | 2010-05-25 | 2010-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201710439UA true SG10201710439UA (en) | 2018-01-30 |
Family
ID=45004368
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012086419A SG185737A1 (en) | 2010-05-25 | 2011-05-25 | Methods of purifying polypeptides |
| SG10201710439UA SG10201710439UA (en) | 2010-05-25 | 2011-05-25 | Methods of purifying polypeptides |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012086419A SG185737A1 (en) | 2010-05-25 | 2011-05-25 | Methods of purifying polypeptides |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US20130079272A1 (en) |
| EP (2) | EP3299380A1 (en) |
| JP (3) | JP5934190B2 (en) |
| KR (1) | KR101976853B1 (en) |
| CN (2) | CN107365346A (en) |
| AU (1) | AU2011258254B2 (en) |
| BR (1) | BR112012029904A2 (en) |
| CA (2) | CA3209878A1 (en) |
| ES (1) | ES2637613T5 (en) |
| HK (1) | HK1246328A1 (en) |
| HR (1) | HRP20171095T4 (en) |
| IL (2) | IL223029A0 (en) |
| MX (2) | MX344248B (en) |
| MY (1) | MY161534A (en) |
| NZ (1) | NZ603648A (en) |
| PL (1) | PL2575847T5 (en) |
| RU (1) | RU2594163C2 (en) |
| SG (2) | SG185737A1 (en) |
| SI (1) | SI2575847T2 (en) |
| WO (1) | WO2011150110A1 (en) |
| ZA (1) | ZA201208673B (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2767135T3 (en) * | 2011-10-19 | 2020-06-16 | Novimmune Sa | Methods for purifying antibodies |
| MY172426A (en) | 2011-12-22 | 2019-11-25 | Genentech Inc | Ion exchange membrane chromatography |
| CN102911250B (en) * | 2012-09-29 | 2014-04-16 | 浙江海正药业股份有限公司 | Method for purifying acidic recombinant protein medicament |
| CN103880947B (en) * | 2012-12-21 | 2016-01-13 | 武汉禾元生物科技股份有限公司 | A kind of chromatography method of separating and purifying high-purity recombination human serum albumin |
| WO2014118685A2 (en) * | 2013-01-29 | 2014-08-07 | Dr. Reddy's Laboratories Limited | Method of altering the acidic variant content of antibody |
| WO2014143616A1 (en) * | 2013-03-14 | 2014-09-18 | Qiagen Sciences Llc | Assessing dna quality using real-time pcr and ct values |
| CN104236983A (en) * | 2013-06-14 | 2014-12-24 | 中国科学院大连化学物理研究所 | Method for removing ionic liquid containing long alkyl chain in solution sample |
| WO2015035180A1 (en) * | 2013-09-05 | 2015-03-12 | Genentech, Inc. | Method for chromatography reuse |
| CA3174012A1 (en) | 2013-09-13 | 2015-03-19 | Genentech, Inc. | Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products |
| CA3184564A1 (en) | 2013-09-13 | 2015-03-19 | Genentech, Inc. | Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2 |
| US10376582B2 (en) | 2013-10-16 | 2019-08-13 | Outlook Therapeutics, Inc. | Buffer formulations for enhanced antibody stability |
| US8859252B1 (en) | 2014-01-02 | 2014-10-14 | Aerial Biopharma, Llc | Prostatic acid phosphatase, compositions comprising the same, and methods for producing and/or purifying the same |
| US10214747B2 (en) | 2014-01-09 | 2019-02-26 | Kentucky Bioprocessing, Inc. | Method of purifying monoclonal antibodies |
| EP3674310A1 (en) | 2014-03-10 | 2020-07-01 | Richter Gedeon Nyrt. | Immunoglobulin purification using pre-cleaning steps |
| ES2719748T3 (en) | 2014-05-23 | 2019-07-12 | Inst Massone S A | Process to obtain HMG-UP (human menopausal gonadotropin with ultrapure grade) and a contaminant-free composition |
| WO2015198320A1 (en) * | 2014-06-24 | 2015-12-30 | Insight Biopharmaceuticals Ltd. | Methods of purifying antibodies |
| GB201411802D0 (en) | 2014-07-02 | 2014-08-13 | Univ Bradford | Effervescent compositions |
| US10696735B2 (en) * | 2015-01-21 | 2020-06-30 | Outlook Therapeutics, Inc. | Modulation of charge variants in a monoclonal antibody composition |
| EP3411401A1 (en) | 2016-02-03 | 2018-12-12 | Oncobiologics, Inc. | Buffer formulations for enhanced antibody stability |
| WO2017218977A2 (en) | 2016-06-17 | 2017-12-21 | Genentech, Inc. | Purification of multispecific antibodies |
| MX2019001572A (en) | 2016-08-15 | 2019-08-29 | Genentech Inc | Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide. |
| JP6564539B1 (en) | 2018-09-14 | 2019-08-21 | 長瀬産業株式会社 | Peptide purification method using sulfonic acid compound |
| WO2020132452A1 (en) | 2018-12-20 | 2020-06-25 | Shire Human Genetic Therapies, Inc. | Purification of iduronate-2-sulfatase immunoglobulin fusion protein |
| CN109765307B (en) * | 2018-12-24 | 2021-06-29 | 山东省科学院海洋仪器仪表研究所 | Method for measuring hexachlorocyclohexane in water body |
| CN111366547A (en) * | 2018-12-26 | 2020-07-03 | 贵州中烟工业有限责任公司 | Detection method for determining α -amino nitrogen in tobacco or tobacco products by using continuous flow method |
| CN113302197A (en) | 2019-01-23 | 2021-08-24 | 第一三共株式会社 | Method for purifying antibody including process using activated carbon material |
| TW202112799A (en) * | 2019-06-05 | 2021-04-01 | 美商建南德克公司 | A method for regeneration of an overload chromatography column |
| WO2021076489A1 (en) * | 2019-10-14 | 2021-04-22 | Pierce Biotechnology, Inc. | Peptide purification formulations and methods |
| US20230251269A1 (en) * | 2020-07-15 | 2023-08-10 | The Johns Hopkins University | Comprehensive analysis of anti-allergen antibodies using phage display |
| CN112852876B (en) * | 2021-03-04 | 2022-11-29 | 西南大学 | Silkworm silk gland recombinant expression vector for expressing human epidermal growth factor and preparation method and application thereof |
| KR20230165245A (en) | 2021-03-31 | 2023-12-05 | 에프. 호프만-라 로슈 아게 | Purification of antibodies by mixed mode chromatography |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| FR2413974A1 (en) | 1978-01-06 | 1979-08-03 | David Bernard | DRYER FOR SCREEN-PRINTED SHEETS |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| DE3889546T2 (en) | 1987-12-21 | 1994-09-08 | Univ Toledo | TRANSFORMATION OF Germinating PLANT SEEDS WITH THE HELP OF AGROBACTERIUM. |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| FR2646437B1 (en) | 1989-04-28 | 1991-08-30 | Transgene Sa | NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (en) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE |
| ATE144793T1 (en) | 1989-06-29 | 1996-11-15 | Medarex Inc | BISPECIFIC REAGENTS FOR AIDS THERAPY |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| EP0586505A1 (en) | 1991-05-14 | 1994-03-16 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
| DE69233254T2 (en) | 1991-06-14 | 2004-09-16 | Genentech, Inc., South San Francisco | Humanized Heregulin antibody |
| MX9204374A (en) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | RECOMBINANT ANTIBODY AND METHOD FOR ITS PRODUCTION. |
| ES2136092T3 (en) | 1991-09-23 | 1999-11-16 | Medical Res Council | PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES. |
| US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| CA2122732C (en) | 1991-11-25 | 2008-04-08 | Marc D. Whitlow | Multivalent antigen-binding proteins |
| DE69333807T2 (en) | 1992-02-06 | 2006-02-02 | Chiron Corp., Emeryville | MARKERS FOR CANCER AND BIOSYNTHETIC BINDEPROTEIN THEREFOR |
| JP3571337B2 (en) | 1992-02-11 | 2004-09-29 | セル ジェネシス，インコーポレーテッド | Homozygous gene conjugation by gene targeting |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| CA2140280A1 (en) | 1992-08-17 | 1994-03-03 | Avi J. Ashkenazi | Bispecific immunoadhesins |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| JP3095175B2 (en) | 1992-11-13 | 2000-10-03 | アイデック ファーマシューティカルズ コーポレイション | Therapeutic use of chimeric and radiolabeled antibodies against human B lymphocyte restricted differentiation antigen for the treatment of B cell lymphoma |
| US5545328A (en) * | 1993-09-21 | 1996-08-13 | Hemosol Inc. | Purification of hemoglobin by displacement chromatography |
| CA2106612C (en) * | 1993-09-21 | 2001-02-06 | Diana Pliura | Displacement chromatography process |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| WO1997027757A1 (en) * | 1996-01-31 | 1997-08-07 | John Stephen Ayers | Production of an immunoglobulin enriched fraction from whey protein solutions |
| US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
| US20020032315A1 (en) | 1997-08-06 | 2002-03-14 | Manuel Baca | Anti-vegf antibodies |
| DE69907439T3 (en) * | 1998-05-06 | 2014-01-02 | Genentech, Inc. | Purification of proteins by ion exchange chromatography |
| SE526227C2 (en) * | 2002-05-15 | 2005-08-02 | North China Pharmaceutical Group | Method of purifying recombinant human serum albumin |
| RU2367667C2 (en) | 2004-08-19 | 2009-09-20 | Дженентек, Инк. | Polypeptide variants with changed effector function |
| CA2580141C (en) | 2004-09-23 | 2013-12-10 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| US7867784B2 (en) | 2004-10-21 | 2011-01-11 | Ge Healthcare Bio-Science Ab | Chromatography ligand |
| KR101482791B1 (en) * | 2005-03-11 | 2015-01-21 | 와이어쓰 엘엘씨 | A method of weak partitioning chromatography |
| NZ562949A (en) * | 2005-04-11 | 2009-05-31 | Medarex Inc | Protein purification using HCIC and ion exchange chromatography |
| US7691980B2 (en) * | 2007-01-09 | 2010-04-06 | Bio-Rad Laboratories, Inc. | Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers |
| US9433922B2 (en) * | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
| KR101241486B1 (en) * | 2007-10-30 | 2013-03-15 | 제넨테크, 인크. | Antibody purification by cation exchange chromatography |
| JP5999899B2 (en) | 2008-04-08 | 2016-09-28 | バイオ−ラッド ラボラトリーズ インコーポレーティッド | Chromatographic purification of antibodies |
| WO2010019148A1 (en) † | 2008-08-14 | 2010-02-18 | Genentech, Inc. | Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography |
| US8497358B2 (en) | 2008-12-19 | 2013-07-30 | Takeda Pharmaceutical Company Limited | Antibody purification method |
| AU2010221099A1 (en) * | 2009-03-06 | 2011-09-22 | Medimmune, Llc | Humanized anti-CD19 antibody formulations |
| EP2480561B1 (en) * | 2009-09-23 | 2016-07-13 | E. R. Squibb & Sons, L.L.C. | Cation exchange chromatography |
-
2011
- 2011-05-25 MX MX2012013575A patent/MX344248B/en active IP Right Grant
- 2011-05-25 CA CA3209878A patent/CA3209878A1/en active Pending
- 2011-05-25 SI SI201131267T patent/SI2575847T2/en unknown
- 2011-05-25 EP EP17167800.6A patent/EP3299380A1/en active Pending
- 2011-05-25 KR KR1020127033600A patent/KR101976853B1/en active IP Right Grant
- 2011-05-25 CN CN201710269454.2A patent/CN107365346A/en active Pending
- 2011-05-25 SG SG2012086419A patent/SG185737A1/en unknown
- 2011-05-25 BR BR112012029904A patent/BR112012029904A2/en not_active Application Discontinuation
- 2011-05-25 JP JP2013512218A patent/JP5934190B2/en active Active
- 2011-05-25 CN CN2011800254040A patent/CN102905718A/en active Pending
- 2011-05-25 WO PCT/US2011/037977 patent/WO2011150110A1/en active Application Filing
- 2011-05-25 SG SG10201710439UA patent/SG10201710439UA/en unknown
- 2011-05-25 RU RU2012156271/04A patent/RU2594163C2/en active
- 2011-05-25 PL PL11787363.8T patent/PL2575847T5/en unknown
- 2011-05-25 NZ NZ603648A patent/NZ603648A/en unknown
- 2011-05-25 HR HRP20171095TT patent/HRP20171095T4/en unknown
- 2011-05-25 AU AU2011258254A patent/AU2011258254B2/en active Active
- 2011-05-25 EP EP11787363.8A patent/EP2575847B2/en active Active
- 2011-05-25 ES ES11787363T patent/ES2637613T5/en active Active
- 2011-05-25 MY MYPI2012005025A patent/MY161534A/en unknown
- 2011-05-25 CA CA2799915A patent/CA2799915C/en active Active
- 2011-05-25 MX MX2016016228A patent/MX370828B/en unknown
-
2012
- 2012-11-14 IL IL223029A patent/IL223029A0/en active IP Right Grant
- 2012-11-19 ZA ZA2012/08673A patent/ZA201208673B/en unknown
- 2012-11-20 US US13/682,620 patent/US20130079272A1/en not_active Abandoned
-
2016
- 2016-05-06 JP JP2016093347A patent/JP6272941B2/en active Active
-
2018
- 2018-01-04 JP JP2018000140A patent/JP2018087192A/en active Pending
- 2018-05-08 HK HK18105945.5A patent/HK1246328A1/en unknown
- 2018-08-14 IL IL261147A patent/IL261147A/en unknown
- 2018-10-22 US US16/167,364 patent/US20190300566A1/en not_active Abandoned
-
2020
- 2020-01-22 US US16/749,888 patent/US20200399307A1/en not_active Abandoned
-
2021
- 2021-07-07 US US17/369,765 patent/US20220064209A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261147A (en) | Methods of purifying polypeptides | |
| HK1246330A1 (en) | Protein purification | |
| IL225650A0 (en) | Processes for purification of proteins | |
| EP3715356C0 (en) | Method of purifying polypeptides | |
| HK1182719A1 (en) | Polypeptides | |
| PT2539136T (en) | Methods of connecting | |
| GB201004638D0 (en) | Separation of gases | |
| IL222900A (en) | Forms of rifaximin | |
| ME02162B (en) | Process for purifying proteins | |
| GB201107987D0 (en) | Bridge | |
| EP2619333A4 (en) | Native-extension parallel sequencing | |
| SG10201501080VA (en) | Method For The Determination Of Sequence Variants Of Polypeptides | |
| HK1162953A1 (en) | Novel use of hesperetin | |
| HK1160777A1 (en) | Novel use of neohesperidoside | |
| GB201012110D0 (en) | Separation of gases | |
| GB201001710D0 (en) | Separation of gases | |
| GB201001193D0 (en) | Separation of gases | |
| HU1000688D0 (en) | Use of trifluoro-phal | |
| TWM390349U (en) | Structure of door-in-door | |
| TWM386865U (en) | Residue-filtering structure of juice-extractor | |
| GB201004059D0 (en) | Method of construction | |
| TWM400763U (en) | Improved structure of cold-accumulating cravats | |
| TWM388315U (en) | Improved structure of hemoclip | |
| TWM390745U (en) | Structure improvement of tea-making can |